92 related articles for article (PubMed ID: 10514547)
1. Origin of selective inhibition of mitochondrial complex I by pyridinium-type inhibitor MP-24.
Iwata J; Miyoshi H; Iwamura H
Biochim Biophys Acta; 1999 Oct; 1413(2):63-9. PubMed ID: 10514547
[TBL] [Abstract][Full Text] [Related]
2. Specificity of pyridinium inhibitors of the ubiquinone reduction sites in mitochondrial complex I.
Miyoshi H; Iwata J; Sakamoto K; Furukawa H; Takada M; Iwamura H; Watanabe T; Kodama Y
J Biol Chem; 1998 Jul; 273(28):17368-74. PubMed ID: 9651320
[TBL] [Abstract][Full Text] [Related]
3. Probing the ubiquinone reduction site in bovine mitochondrial complex I using a series of synthetic ubiquinones and inhibitors.
Miyoshi H
J Bioenerg Biomembr; 2001 Jun; 33(3):223-31. PubMed ID: 11695832
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases.
Satoh T; Miyoshi H; Sakamoto K; Iwamura H
Biochim Biophys Acta; 1996 Jan; 1273(1):21-30. PubMed ID: 8573592
[TBL] [Abstract][Full Text] [Related]
5. Probing the ubiquinone reduction site of mitochondrial complex I using novel cationic inhibitors.
Miyoshi H; Inoue M; Okamoto S; Ohshima M; Sakamoto K; Iwamura H
J Biol Chem; 1997 Jun; 272(26):16176-83. PubMed ID: 9195916
[TBL] [Abstract][Full Text] [Related]
6. N-alkyl pyridiniums as inhibitors of complex 1.
Tian YM; Griffiths DE
Biochem Soc Trans; 1994 Feb; 22(1):71S. PubMed ID: 8206302
[No Abstract] [Full Text] [Related]
7. Comparison of the structural features of ubiquinone reduction sites between glucose dehydrogenase in Escherichia coli and bovine heart mitochondrial complex I.
Sakamoto K; Miyoshi H; Matsushita K; Nakagawa M; Ikeda J; Ohshima M; Adachi O; Akagi T; Iwamura H
Eur J Biochem; 1996 Apr; 237(1):128-35. PubMed ID: 8620864
[TBL] [Abstract][Full Text] [Related]
8. Structural factors of rotenone required for inhibition of various NADH-ubiquinone oxidoreductases.
Ueno H; Miyoshi H; Inoue M; Niidome Y; Iwamura H
Biochim Biophys Acta; 1996 Sep; 1276(3):195-202. PubMed ID: 8856105
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis of three conserved Glu residues in a bacterial homologue of the ND1 subunit of complex I affects ubiquinone reduction kinetics but not inhibition by dicyclohexylcarbodiimide.
Kurki S; Zickermann V; Kervinen M; Hassinen I; Finel M
Biochemistry; 2000 Nov; 39(44):13496-502. PubMed ID: 11063586
[TBL] [Abstract][Full Text] [Related]
10. New evidence for the multiplicity of ubiquinone- and inhibitor-binding sites in the mitochondrial complex I.
Tormo JR; Estornell E
Arch Biochem Biophys; 2000 Sep; 381(2):241-6. PubMed ID: 11032411
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparations.
Gluck MR; Krueger MJ; Ramsay RR; Sablin SO; Singer TP; Nicklas WJ
J Biol Chem; 1994 Feb; 269(5):3167-74. PubMed ID: 8106350
[TBL] [Abstract][Full Text] [Related]
12. Dynamic function of the spacer region of acetogenins in the inhibition of bovine mitochondrial NADH-ubiquinone oxidoreductase (complex I).
Abe M; Kubo A; Yamamoto S; Hatoh Y; Murai M; Hattori Y; Makabe H; Nishioka T; Miyoshi H
Biochemistry; 2008 Jun; 47(23):6260-6. PubMed ID: 18476722
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of complex I by hydrophobic analogues of N-methyl-4-phenylpyridinium (MPP+) and the use of an ion-selective electrode to measure their accumulation by mitochondria and electron-transport particles.
Murphy MP; Krueger MJ; Sablin SO; Ramsay RR; Singer TP
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):359-65. PubMed ID: 7887889
[TBL] [Abstract][Full Text] [Related]
14. Arylazido-beta-alanine ADP-ribose, a novel irreversible competitive inhibitor of mitochondrial NADH-ubiquinone reductase.
Frenkin MV; Kotlyar AB
Biochim Biophys Acta; 1999 Nov; 1413(3):139-46. PubMed ID: 10556626
[TBL] [Abstract][Full Text] [Related]
15. Binding of detergents and inhibitors to bovine complex I - a novel purification procedure for bovine complex I retaining full inhibitor sensitivity.
Okun JG; Zickermann V; Zwicker K; Schägger H; Brandt U
Biochim Biophys Acta; 2000 Jul; 1459(1):77-87. PubMed ID: 10924901
[TBL] [Abstract][Full Text] [Related]
16. Hybrid ubiquinone: novel inhibitor of mitochondrial complex I.
Yabunaka H; Kenmochi A; Nakatogawa Y; Sakamoto K; Miyoshi H
Biochim Biophys Acta; 2002 Dec; 1556(2-3):106-12. PubMed ID: 12460667
[TBL] [Abstract][Full Text] [Related]
17. Triton X-100 as a specific inhibitor of the mammalian NADH-ubiquinone oxidoreductase (Complex I).
Ushakova AV; Grivennikova VG; Ohnishi T; Vinogradov AD
Biochim Biophys Acta; 1999 Jan; 1409(3):143-53. PubMed ID: 9878712
[TBL] [Abstract][Full Text] [Related]
18. Crucial structural factors and mode of action of polyene amides as inhibitors for mitochondrial NADH-ubiquinone oxidoreductase (complex I).
Yoshida T; Murai M; Abe M; Ichimaru N; Harada T; Nishioka T; Miyoshi H
Biochemistry; 2007 Sep; 46(36):10365-72. PubMed ID: 17685634
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of NADH dehydrogenase (complex I) inhibited by 1-methyl-4-(4'-alkylphenyl)pyridinium analogues: a clue to the nature of the inhibition site.
Krueger MJ; Sablin SO; Ramsay R; Singer TP
J Neurochem; 1993 Oct; 61(4):1546-8. PubMed ID: 8377005
[TBL] [Abstract][Full Text] [Related]
20. Role of the isoprenyl tail of ubiquinone in reaction with respiratory enzymes: studies with bovine heart mitochondrial complex I and Escherichia coli bo-type ubiquinol oxidase.
Sakamoto K; Miyoshi H; Ohshima M; Kuwabara K; Kano K; Akagi T; Mogi T; Iwamura H
Biochemistry; 1998 Oct; 37(43):15106-13. PubMed ID: 9790673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
